Skip to main content

Advertisement

SpringerLink
Log in

Combined Measurement of Hepatocyte Growth Factor and Carcinoembryonic Antigen as a Prognostic Marker for Patients with Dukes A and B Colorectal Cancer: Results of a Five-Year Study

  • Published:
Diseases of the Colon & Rectum

Purpose

There is no marker capable of differentiating patients with Dukes A and B colorectal cancer with aggressive diseases from those with indolent diseases. We evaluated the results of five years of actuarial survival data to determine whether serial monitoring of serum hepatocyte growth factor could provide prognostic information on these patients.

Methods

Blood samples of 147 colorectal cancer patients were obtained and the serum concentration of hepatocyte growth factor was measured.

Results

Elevated serum hepatocyte growth factor levels were associated with stage progression. Although the overall positive rate of hepatocyte growth factor in the patients was the same as that of the carcinoembryonic antigen, the positive rate of hepatocyte growth factor in the Dukes A patients was two times higher than that of the carcinoembryonic antigen, and nearly 40 percent of the carcinoembryonic antigen-negative patients had a positive serum hepatocyte growth factor in the Dukes A and B classification. In this subgroup, patients with positive serum hepatocyte growth factor or carcinoembryonic antigen levels had a poorer prognosis, whereas positive serum hepatocyte growth factor level after surgery could predict disease recurrence.

Conclusions

A combination of serum hepatocyte growth factor and carcinoembryonic antigen tests might be useful for selecting patients with aggressive diseases in Dukes A and B classification.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5

Similar content being viewed by others

References

  1. A Wein EG Hahn S Merkel W Hohenberger (2000) ArticleTitleAdjuvant chemotherapy for stage II colon cancer Eur J Surg Oncol 26 730–732 Occurrence Handle11087635 Occurrence Handle1:STN:280:DC%2BD3M7jvFKnsw%3D%3D Occurrence Handle10.1053/ejso.2000.0993

    Article  PubMed  CAS  Google Scholar 

  2. MJ Duffy (2001) ArticleTitleCarcinoembryonic antigen as a marker for colorectal cancer: is it clinically useful? Clin Chem 47 624–630 Occurrence Handle11274010 Occurrence Handle1:CAS:528:DC%2BD3MXis1Kjur0%3D

    PubMed  CAS  Google Scholar 

  3. P Gold SO Freedman (1965) ArticleTitleDemonstration of tumor-specific antigens in human colonic carcinoma by immunological tolerance and absorption techniques J Exp Med 121 439–462 Occurrence Handle14270243 Occurrence Handle1:STN:280:CCqD2svnvFw%3D Occurrence Handle10.1084/jem.121.3.439

    Article  PubMed  CAS  Google Scholar 

  4. P Gold SO Freedman (1965) ArticleTitleSpecific carcinoembryonic antigens of the human digestive system J Exp Med 122 467–481 Occurrence Handle4953873 Occurrence Handle1:CAS:528:DyaF2MXltVaitLY%3D Occurrence Handle10.1084/jem.122.3.467

    Article  PubMed  CAS  Google Scholar 

  5. CC Compton LP Fielding LJ Burgart et al. (2000) ArticleTitlePrognostic factors in colorectal cancer Arch Pathol Lab Med 124 979–994 Occurrence Handle10888773 Occurrence Handle1:STN:280:DC%2BD3czptVKrug%3D%3D

    PubMed  CAS  Google Scholar 

  6. CG Moertel TR Fleming JS Macdonald DG Haller JA Laurie C Tangen (1993) ArticleTitleAn evaluation of the carcinoembryonic antigen (CEA) test for monitoring patients with resected colon cancer JAMA 270 943–947 Occurrence Handle8141873 Occurrence Handle1:STN:280:ByyA2cjjvVw%3D Occurrence Handle10.1001/jama.270.8.943

    Article  PubMed  CAS  Google Scholar 

  7. T Nakamura K Nawa A Ichihara N Kaise T Nishino (1987) ArticleTitlePurification and subunit structure of hepatocyte growth factor from rat platelets FEBS Lett 224 311–316 Occurrence Handle3319692 Occurrence Handle1:CAS:528:DyaL1cXkvFCntQ%3D%3D Occurrence Handle10.1016/0014-5793(87)80475-1

    Article  PubMed  CAS  Google Scholar 

  8. E Gohda H Tsubouchi H Nakayama et al. (1988) ArticleTitlePurification and partial characterization of hepatocyte growth factor from plasma of a patient with fulminant hepatic failure J Clin Invest 81 414–419 Occurrence Handle3276728 Occurrence Handle1:CAS:528:DyaL1cXitFKns7s%3D Occurrence Handle10.1172/JCI113334

    Article  PubMed  CAS  Google Scholar 

  9. R Zarnegar G Michalopoulos (1989) ArticleTitlePurification and biological characterization of human hepatopoietin A, a polypeptide growth factor for hepatocytes Cancer Res 49 3314–3320 Occurrence Handle2524251 Occurrence Handle1:CAS:528:DyaL1MXktlektrY%3D

    PubMed  CAS  Google Scholar 

  10. M Stoker E Gherardi M Perryman J Gray (1987) ArticleTitleScatter factor is a fibroblast-derived modulator of epithelial cell mobility Nature 327 239–242 Occurrence Handle2952888 Occurrence Handle1:STN:280:BiiB3c7ps1I%3D Occurrence Handle10.1038/327239a0

    Article  PubMed  CAS  Google Scholar 

  11. K Weidner N Arakaki G Hartmann et al. (1991) ArticleTitleEvidence for the identity of human scatter factor and human hepatocyte growth factor Proc Natl Acad Sci USA 88 7001–7005 Occurrence Handle1831266 Occurrence Handle1:CAS:528:DyaK38XlsVelsbY%3D Occurrence Handle10.1073/pnas.88.16.7001

    Article  PubMed  CAS  Google Scholar 

  12. L Naldini KM Weidner E Vigna et al. (1991) ArticleTitleScatter factor and hepatocyte growth factor are indistinguishable ligands for the MET receptor EMBO J 10 2867–2878 Occurrence Handle1655405 Occurrence Handle1:CAS:528:DyaK3MXmsVyktrg%3D

    PubMed  CAS  Google Scholar 

  13. R Zarnegar GK Michalopoulos (1995) ArticleTitleThe many faces of hepatocyte growth factor: from hepatopoiesis to hematopoiesis J Cell Biol 129 1177–1180 Occurrence Handle7775566 Occurrence Handle1:CAS:528:DyaK2MXlvVWntr4%3D Occurrence Handle10.1083/jcb.129.5.1177

    Article  PubMed  CAS  Google Scholar 

  14. K Matsumoto T Nakamura (1996) ArticleTitleEmerging multipotent aspects of hepatocyte growth factor J Biochem (Tokyo) 119 591–600 Occurrence Handle1:CAS:528:DyaK28Xkt1Oisb0%3D

    CAS  Google Scholar 

  15. S Bellusci G Moens G Gaudino et al. (1994) ArticleTitleCreation of a hepatocyte growth factor/scatter factor autocrine loop in carcinoma cells induces invasive properties associated with increased tumorigenicity Oncogene 9 1091–1099 Occurrence Handle8134112 Occurrence Handle1:CAS:528:DyaK2cXis1Ojtr8%3D

    PubMed  CAS  Google Scholar 

  16. S Rong S Segal M Anver JH Resau GF Woude ParticleVande (1994) ArticleTitleInvasiveness and metastasis of NIH3T3 cells induced by Met-hepatocyte growth factor/scatter factor autocrine stimulation Proc Natl Acad Sci USA 91 4731–4735 Occurrence Handle8197126 Occurrence Handle1:CAS:528:DyaK2cXktlahs7Y%3D Occurrence Handle10.1073/pnas.91.11.4731

    Article  PubMed  CAS  Google Scholar 

  17. K Lamszus L Jin A Fuchs et al. (1997) ArticleTitleScatter factor stimulates tumor growth and tumor angiogenesis in human breast cancers in the mammary fat pad of nude mice Lab Invest 76 339–353 Occurrence Handle9121117 Occurrence Handle1:CAS:528:DyaK2sXis1Gruro%3D

    PubMed  CAS  Google Scholar 

  18. T Nakamura K Matsumoto A Kiritoshi et al. (1997) ArticleTitleInduction of hepatocyte growth factor in fibroblasts by tumor-derived factors affects invasive growth of tumor cells: in vitro analysis of tumor-stromal interactions Cancer Res 57 3305–3313 Occurrence Handle9242465 Occurrence Handle1:CAS:528:DyaK2sXkvFKqurg%3D

    PubMed  CAS  Google Scholar 

  19. R Abounader S Ranganathan B Lal et al. (1999) ArticleTitleReversion of human glioblastoma malignancy by U1 small nuclear RNA/ribozyme targeting of scatter factor/hepatocyte growth factor and c-met expression J Natl Cancer Inst 91 1548–1556 Occurrence Handle10491431 Occurrence Handle1:CAS:528:DyaK1MXmsVCrt7o%3D Occurrence Handle10.1093/jnci/91.18.1548

    Article  PubMed  CAS  Google Scholar 

  20. D Ronen RT Alstock M Firon et al. (1999) ArticleTitleMet-HGF/SF mediates growth arrest and differentiation in T47D breast cancer cells Cell Growth Differ 10 131–140 Occurrence Handle10074906 Occurrence Handle1:CAS:528:DyaK1MXhsFelt7Y%3D

    PubMed  CAS  Google Scholar 

  21. T Fukuura C Miki T Inoue K Matsumoto H Suzuki (1998) ArticleTitleSerum hepatocyte growth factor as an index of disease status of patients with colorectal carcinoma Br J Cancer 78 454–459 Occurrence Handle9716026 Occurrence Handle1:CAS:528:DyaK1cXlslWjtbk%3D

    PubMed  CAS  Google Scholar 

  22. GA Vargas A Hoeflich PM Jehle (2000) ArticleTitleHepatocyte growth factor in renal failure: promise and reality Kidney Int 57 1426–1435 Occurrence Handle10760078 Occurrence Handle1:CAS:528:DC%2BD3cXjtVOrt7w%3D Occurrence Handle10.1046/j.1523-1755.2000.00987.x

    Article  PubMed  CAS  Google Scholar 

  23. T Taniguchi M Kitamura K Araki et al. (1997) ArticleTitleIncrease in the circulating level of hepatocyte growth factor in gastric cancer patients Br J Cancer 75 673–677 Occurrence Handle9043023 Occurrence Handle1:STN:280:ByiC1MrmsFQ%3D

    PubMed  CAS  Google Scholar 

  24. N Takigawa Y Segawa Y Maeda I Takata N Fujimoto (1997) ArticleTitleSerum hepatocyte growth factor/scatter factor levels in small lung cancer patients Lung Cancer 17 211–218 Occurrence Handle9237156 Occurrence Handle1:STN:280:ByiA1c%2Fjs1I%3D Occurrence Handle10.1016/S0169-5002(97)00651-X

    Article  PubMed  CAS  Google Scholar 

  25. M Toi T Taniguchi T Ueno et al. (1998) ArticleTitleSignificance of circulating hepatocyte growth factor level as a prognostic indicator in primary breast cancer Clin Cancer Res 4 659–664 Occurrence Handle9533534 Occurrence Handle1:STN:280:DyaK1c7pt1ajtw%3D%3D

    PubMed  CAS  Google Scholar 

  26. M Naughton J Picus X Zhu WJ Catalona RT Vollmer PA Humphrey (2001) ArticleTitleScatter factor-hepatocyte growth factor elevation in the serum of patients with prostate cancer J Urol 165 1325–1328 Occurrence Handle11257710 Occurrence Handle1:CAS:528:DC%2BD3MXisVygs7k%3D Occurrence Handle10.1016/S0022-5347(01)69893-8

    Article  PubMed  CAS  Google Scholar 

  27. H Yamagami M Moriyama H Matsumura et al. (2002) ArticleTitleSerum concentration of human hepatocyte growth factor is a useful indicator for predicting the occurrence of hepatocellular carcinomas in C-viral chronic liver diseases Cancer 95 824–834 Occurrence Handle10.1002/cncr.10732 Occurrence Handle1:CAS:528:DC%2BD38Xms1Shur0%3D

    Article  CAS  Google Scholar 

  28. MG Alexandrakis FH Passam A Sfridaki E Kandidaki P Roussou DS Kyriakou (2003) ArticleTitleElevated serum concentration of hepatocyte growth factor in patients with multiple myeloma: correlation with markers of disease activity Am J Hematol 72 229–233 Occurrence Handle12666132 Occurrence Handle1:CAS:528:DC%2BD3sXjtVChu7k%3D Occurrence Handle10.1002/ajh.10304

    Article  PubMed  CAS  Google Scholar 

  29. LT Hsiao JT Lin IT Yu et al. (2003) ArticleTitleHigh serum hepatocyte growth factor level in patients with non-Hodgkin’s lymphoma Eur J Haematol 70 282–289 Occurrence Handle12694163 Occurrence Handle1:CAS:528:DC%2BD3sXkt1Sjurg%3D Occurrence Handle10.1034/j.1600-0609.2003.00059.x

    Article  PubMed  CAS  Google Scholar 

  30. D Vesely J Astl P Lastuvka P Matucha I Sterzl J Betka (2004) ArticleTitleSerum levels of IGF-1, HGF, TGF beta 1, bFGF and VEGF in thyroid gland tumors Physiol Res 53 83–89 Occurrence Handle14984318 Occurrence Handle1:CAS:528:DC%2BD2cXivFKjs7g%3D

    PubMed  CAS  Google Scholar 

  31. K Tanaka C Miki R Wakuda M Kobayashi H Tonouchi M Kusunoki (2004) ArticleTitleCirculating level of hepatocyte growth factor as a useful tumor marker in patients with early-stage gastric carcinoma Scand J Gastroenterol 39 IssueID8 754–760 Occurrence Handle15513361 Occurrence Handle1:CAS:528:DC%2BD2cXnslantb4%3D Occurrence Handle10.1080/00365520410005973

    Article  PubMed  CAS  Google Scholar 

  32. S Kermorgant G Cadiot MJ Lewin T Lehy (1996) ArticleTitleExpression of hepatocyte growth factor and its receptor, C-Met in human digestive tissues and different gastric and colonic cancer cell lines Gastroenterol Clin Biol 20 438–445 Occurrence Handle8761141 Occurrence Handle1:CAS:528:DyaK28XkslCntbg%3D

    PubMed  CAS  Google Scholar 

  33. RH Hu PH Lee SC Yu JC Sheu MY Lai (1999) ArticleTitleSerum hepatocyte growth factor before and after resection for hepatocellular carcinoma Hepatogastroenterology 46 1842–1847 Occurrence Handle10430357 Occurrence Handle1:STN:280:DyaK1MzlslChtA%3D%3D

    PubMed  CAS  Google Scholar 

  34. B Bilezikci AN Haberal B Demirhan (2001) ArticleTitleHepatocyte growth factor in patients with three different stages of chronic liver disease including hepatocellular carcinoma, cirrhosis and chronic hepatitis: an immunohistochemical study Can J Gastroenterol 15 159–165 Occurrence Handle11264569 Occurrence Handle1:STN:280:DC%2BD3M7ms1GrtQ%3D%3D

    PubMed  CAS  Google Scholar 

  35. JM Otte F Schmitz K Kiehne et al. (2000) ArticleTitleFunctional expression of HGF and its receptor in human colorectal cancer Digestion 61 237–246 Occurrence Handle10878450 Occurrence Handle1:CAS:528:DC%2BD3cXlsFWjsLs%3D Occurrence Handle10.1159/000007764

    Article  PubMed  CAS  Google Scholar 

  36. JA Thompson F Grunert W Zimmermann (1991) ArticleTitleCarcinoembryonic antigen gene family: molecular biology and clinical perspectives J Clin Lab Anal 5 344–366 Occurrence Handle1941355 Occurrence Handle1:CAS:528:DyaK3MXmslWlsLs%3D

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Gastrointestinal and Pediatric Surgery, Mie University Graduate School of Medicine, Edobashi 2-174 Tsu, Mie, 514-8507, Japan

    Chikao Miki M.D., Yasuhiro Inoue M.D., Jun-ichiro Hiro M.D., Eiki Ojima M.D., Toshimitsu Araki M.D., Keiichi Uchida M.D. & Masato Kusunoki M.D.

Authors
  1. Chikao Miki M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Yasuhiro Inoue M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Jun-ichiro Hiro M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Eiki Ojima M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Toshimitsu Araki M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Keiichi Uchida M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Masato Kusunoki M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Chikao Miki M.D..

About this article

Cite this article

Miki, C., Inoue, Y., Hiro, Ji. et al. Combined Measurement of Hepatocyte Growth Factor and Carcinoembryonic Antigen as a Prognostic Marker for Patients with Dukes A and B Colorectal Cancer: Results of a Five-Year Study. Dis Colon Rectum 49, 1710–1718 (2006). https://doi.org/10.1007/s10350-006-0697-9

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10350-006-0697-9

Key words

Search

Navigation